Human Brain Lipidomics: Pilot Analysis of the Basal Ganglia Sphingolipidome in Parkinson’s Disease and Lewy Body Disease
Sphingolipids constitute a complex class of bioactive lipids with diverse structural and functional roles in neural tissue. Lipidomic techniques continue to provide evidence for their association in neurological diseases, including Parkinson’s disease (PD) and Lewy body disease (LBD). However, prior...
Main Authors: | Aaron W. Beger, Beatrix Dudzik, Randall L. Woltjer, Paul L. Wood |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Metabolites |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-1989/12/2/187 |
Similar Items
-
Targeted Analysis of Sphingolipids in Turkeys Fed Fusariotoxins: First Evidence of Key Changes That Could Help Explain Their Relative Resistance to Fumonisin Toxicity
by: Philippe Guerre, et al.
Published: (2022-02-01) -
Selective knockdown of ceramide synthases reveals complex interregulation of sphingolipid metabolism[S]
by: Thomas D. Mullen, et al.
Published: (2011-01-01) -
Circulating ceramides and sphingomyelins and the risk of incident cardiovascular disease among people with diabetes: the strong heart study
by: Paul N. Jensen, et al.
Published: (2022-08-01) -
Plasma Sphingolipid Profile Associated With Subclinical Atherosclerosis and Clinical Disease Markers of Systemic Lupus Erythematosus: Potential Predictive Value
by: Samar M. Hammad, et al.
Published: (2021-07-01) -
Zymosan-Induced Murine Peritonitis Is Associated with an Increased Sphingolipid Synthesis without Changing the Long to Very Long Chain Ceramide Ratio
by: Alix Pierron, et al.
Published: (2023-02-01)